306 related articles for article (PubMed ID: 30098410)
1. A Large Single-Hospital Experience Using Drug Provocation Testing and Rapid Drug Desensitization in Hypersensitivity to Antineoplastic and Biological Agents.
Madrigal-Burgaleta R; Bernal-Rubio L; Berges-Gimeno MP; Carpio-Escalona LV; Gehlhaar P; Alvarez-Cuesta E
J Allergy Clin Immunol Pract; 2019 Feb; 7(2):618-632. PubMed ID: 30098410
[TBL] [Abstract][Full Text] [Related]
2. Delving into cornerstones of hypersensitivity to antineoplastic and biological agents: value of diagnostic tools prior to desensitization.
Alvarez-Cuesta E; Madrigal-Burgaleta R; Angel-Pereira D; Ureña-Tavera A; Zamora-Verduga M; Lopez-Gonzalez P; Berges-Gimeno MP
Allergy; 2015 Jul; 70(7):784-94. PubMed ID: 25832325
[TBL] [Abstract][Full Text] [Related]
3. Hypersensitivity and desensitization to antineoplastic agents: outcomes of 189 procedures with a new short protocol and novel diagnostic tools assessment.
Madrigal-Burgaleta R; Berges-Gimeno MP; Angel-Pereira D; Ferreiro-Monteagudo R; Guillen-Ponce C; Pueyo C; Gomez de Salazar E; Alvarez-Cuesta E
Allergy; 2013 Jul; 68(7):853-61. PubMed ID: 23647576
[TBL] [Abstract][Full Text] [Related]
4. Rapid Drug Desensitization with Chemotherapeutics (Platins, Taxanes, and Others): A Single-Center Retrospective Study.
Kendirlinan R; Gümüşburun R; Çerçi P; Özbek E; Altıner S; Çelebi Sözener Z; Soyyiğit Ş; Aydın Ö; Bavbek S
Int Arch Allergy Immunol; 2019; 179(2):114-122. PubMed ID: 30893688
[TBL] [Abstract][Full Text] [Related]
5. Rapid desensitization to antineoplastic drugs in an outpatient immunoallergology clinic: Outcomes and risk factors.
Caiado J; Brás R; Paulino M; Costa L; Castells M
Ann Allergy Asthma Immunol; 2020 Sep; 125(3):325-333.e1. PubMed ID: 32353405
[TBL] [Abstract][Full Text] [Related]
6. Assessment of Antihistamines and Corticosteroids as Premedication in Rapid Drug Desensitization to Paclitaxel: Outcomes in 155 Procedures.
Lopez-Gonzalez P; Madrigal-Burgaleta R; Carpio-Escalona LV; Bernal-Rubio L; Guerra E; Berges-Gimeno MP; Alvarez-Cuesta E
J Allergy Clin Immunol Pract; 2018; 6(4):1356-1362. PubMed ID: 29248386
[TBL] [Abstract][Full Text] [Related]
7. Relevance of the diagnosis of hypersensitivity reactions to antineoplastic and biological agents: experience with drug provocation test.
Queirós Gomes J; Pereira Dias LP; Barreira P; Barradas Lopes J; Sousa MJ; Cadinha S; Malheiro D
Eur Ann Allergy Clin Immunol; 2023 May; ():. PubMed ID: 37133313
[No Abstract] [Full Text] [Related]
8. Basophil Activation Test is a Relevant Biomarker of the Outcome of Rapid Desensitization in Platinum Compounds-Allergy.
Giavina-Bianchi P; Galvão VR; Picard M; Caiado J; Castells MC
J Allergy Clin Immunol Pract; 2017; 5(3):728-736. PubMed ID: 28034549
[TBL] [Abstract][Full Text] [Related]
9. Rapid Drug Desensitization with Biologics: A Single-Center Experience with Four Biologics.
Bavbek S; Kendirlinan R; Çerçi P; Altıner S; Soyyiğit Ş; Çelebi Sözener Z; Aydın Ö; Gümüşburun R
Int Arch Allergy Immunol; 2016; 171(3-4):227-233. PubMed ID: 28049204
[TBL] [Abstract][Full Text] [Related]
10. One-Dilution Rapid Desensitization Protocol to Chemotherapeutic and Biological Agents: A Five-Year Experience.
Sala-Cunill A; Molina-Molina GJ; Verdesoto JT; Labrador-Horrillo M; Luengo O; Galvan-Blasco P; Guilarte M; Cardona V
J Allergy Clin Immunol Pract; 2021 Nov; 9(11):4045-4054. PubMed ID: 34214705
[TBL] [Abstract][Full Text] [Related]
11. Does Rapid Drug Desensitization to Chemotherapy Affect Survival Outcomes?
Berges-Gimeno MP; Carpio-Escalona LV; Longo-Muñoz F; Bernal-Rubio L; Lopez-Gonzalez P; Gehlhaar P; Pachon V; Ferreiro-Monteagudo R; Madrigal-Burgaleta R; Alvarez-Cuesta E
J Investig Allergol Clin Immunol; 2020; 30(4):254-263. PubMed ID: 31188129
[TBL] [Abstract][Full Text] [Related]
12. Outcome of 490 Desensitizations to Chemotherapy Drugs with a Rapid One-Solution Protocol.
Pérez-Rodríguez E; Martínez-Tadeo JA; Pérez-Rodríguez N; Hernández-Santana G; Callero-Viera A; Rodríguez-Plata E; García-Robaina JC
J Allergy Clin Immunol Pract; 2018; 6(5):1621-1627.e6. PubMed ID: 29361511
[TBL] [Abstract][Full Text] [Related]
13. Rapid drug desensitization with platin-based chemotherapy: Analysis of risk factors for breakthrough reactions.
Gorgulu Akin B; Erkoc M; Korkmaz ET; Ozdel Ozturk B; Colak S; Ozalp Ates FS; Bavbek S
World Allergy Organ J; 2022 Jan; 15(1):100619. PubMed ID: 34992710
[TBL] [Abstract][Full Text] [Related]
14. Key elements in hypersensitivity reactions to chemotherapy: experience with rapid drug desensitization in gynaecological cancer in a Tertiary Hospital.
Alen Coutinho I; Costa Sousa F; Cunha F; Frutuoso C; Ribeiro C; Loureiro C; Águas F; Todo Bom A
Eur Ann Allergy Clin Immunol; 2022 Nov; 54(6):265-276. PubMed ID: 33944544
[TBL] [Abstract][Full Text] [Related]
15. Oxaliplatin hypersensitivity: evaluation, implications of skin testing, and desensitization.
Wong JT; Ling M; Patil S; Banerji A; Long A
J Allergy Clin Immunol Pract; 2014; 2(1):40-5. PubMed ID: 24565767
[TBL] [Abstract][Full Text] [Related]
16. [Hypersensitivity to platinum salts and taxanes: The value of skin tests and tolerance induction procedures].
Brault F; Waton J; Poreaux C; Schmutz JL; Barbaud A
Ann Dermatol Venereol; 2017 Nov; 144(11):685-695. PubMed ID: 28760501
[TBL] [Abstract][Full Text] [Related]
17. Risk stratification and skin testing to guide re-exposure in taxane-induced hypersensitivity reactions.
Picard M; Pur L; Caiado J; Giavina-Bianchi P; Galvão VR; Berlin ST; Campos SM; Matulonis UA; Castells MC
J Allergy Clin Immunol; 2016 Apr; 137(4):1154-1164.e12. PubMed ID: 26725998
[TBL] [Abstract][Full Text] [Related]
18. Are antineoplastic drug acute hypersensitive reactions a submerged or an emergent problem? Experience of the Medical Day Hospital of the Fondazione IRCCS Istituto Nazionale Tumori.
Ferrari LA; Fanetti G; Rossi FG; Brambilla MC; Re B; Buzzoni R
Tumori; 2014; 100(1):9-14. PubMed ID: 24675484
[TBL] [Abstract][Full Text] [Related]
19. Hypersensitivity to antineoplastic agents: mechanisms and treatment with rapid desensitization.
Castells M; Sancho-Serra Mdel C; Simarro M
Cancer Immunol Immunother; 2012 Sep; 61(9):1575-84. PubMed ID: 22576054
[TBL] [Abstract][Full Text] [Related]
20. Breakthrough reactions during rapid drug desensitization: Clinical outcome and risk factors.
Kang Y; Kwon OY; Jung H; Kang M; An J; Lee JH; Won HK; Song WJ; Kwon HS; Cho YS; Moon HB; Kim TB
Ann Allergy Asthma Immunol; 2019 Jul; 123(1):48-56.e1. PubMed ID: 31108181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
